Aclaris Therapeutics ACRS SEC Filings

NASDAQ ACRS
$3.81 +0.04 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Aclaris Therapeutics, Inc. (ACRS) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
1SCHEDULE 13GBeneficial Ownership0001231919-26-001199Sep 21, 2026 4:09 PM-
28-KCurrent Report0001104659-26-092128Aug 6, 2026 9:15 PM
3S-3ASROthers0001104659-26-092113Aug 6, 2026 9:08 PM
410-QQuarterly & Annual Report0001104659-26-092065Aug 6, 2026 8:31 PM
58-KCurrent Report0001104659-26-091629Aug 6, 2026 11:15 AM
64Insider Transaction0002076327-26-000006Aug 4, 2026 9:03 PM
74Insider Transaction0001590102-26-000002Jun 8, 2026 8:15 PM
84Insider Transaction0001172252-26-000002Jun 8, 2026 8:15 PM
94Insider Transaction0001654773-26-000003Jun 8, 2026 8:15 PM
104Insider Transaction0001674278-26-000002Jun 8, 2026 8:15 PM
114Insider Transaction0001187159-26-000002Jun 8, 2026 8:15 PM
124Insider Transaction0001280044-26-000004Jun 8, 2026 8:15 PM
138-KCurrent Report0001104659-26-070494Jun 4, 2026 8:01 PM
14SCHEDULE 13GBeneficial Ownership Report0001213900-26-055376May 12, 2026 1:48 AM
1510-QQuarterly & Annual Report0001104659-26-057202May 7, 2026 8:32 PM
168-KCurrent Report0001104659-26-056669May 7, 2026 11:15 AM
174Insider Transaction0002065269-26-000004May 5, 2026 8:15 PM
184Insider Transaction0002065269-26-000004May 5, 2026 8:15 PM
198-KCurrent Report0001104659-26-049733Apr 28, 2026 10:45 AM
204Insider Transaction0001373604-26-000034Apr 27, 2026 11:27 PM
21SCHEDULE 13GBeneficial Ownership Report0001373604-26-000033Apr 27, 2026 11:26 PM
22ARSOthers0001104659-26-047264Apr 23, 2026 11:47 AM
23DEFA14AOthers0001104659-26-047263Apr 23, 2026 11:46 AM
24DEF 14AOthers0001104659-26-047262Apr 23, 2026 11:45 AM
25SCHEDULE 13GBeneficial Ownership Report0001346824-26-000099Apr 7, 2026 9:59 PM
26SCHEDULE 13GBeneficial Ownership Report0000102909-26-000505Mar 26, 2026 7:06 PM
27SCHEDULE 13GBeneficial Ownership Report0001172661-26-001355Mar 17, 2026 8:16 PM
288-KCurrent Report0001104659-26-026407Mar 11, 2026 8:30 PM
298-KCurrent Report0001104659-26-025420Mar 10, 2026 1:51 AM
304Insider Transaction0001957554-26-000011Mar 3, 2026 9:10 PM
314Insider Transaction0001957554-26-000011Mar 3, 2026 9:10 PM
324Insider Transaction0001957554-26-000011Mar 3, 2026 9:10 PM
3310-KQuarterly & Annual Report0001104659-26-020540Feb 26, 2026 9:31 PM
348-KCurrent Report0001104659-26-020070Feb 26, 2026 12:15 PM
35SCHEDULE 13GBeneficial Ownership Report0001373604-26-000008Feb 9, 2026 6:42 PM
364Insider Transaction0001604457-26-000007Feb 6, 2026 11:10 PM
374Insider Transaction0001604457-26-000007Feb 6, 2026 11:10 PM
384Insider Transaction0001604457-26-000007Feb 6, 2026 11:10 PM
394Insider Transaction0002045027-26-000004Feb 6, 2026 11:08 PM
404Insider Transaction0002045027-26-000004Feb 6, 2026 11:08 PM
414Insider Transaction0002045027-26-000004Feb 6, 2026 11:08 PM
424Insider Transaction0002076327-26-000002Feb 6, 2026 11:06 PM
434Insider Transaction0002076327-26-000002Feb 6, 2026 11:06 PM
444Insider Transaction0002076327-26-000002Feb 6, 2026 11:06 PM
454Insider Transaction0002065269-26-000002Feb 6, 2026 11:04 PM
464Insider Transaction0001781549-26-000013Feb 6, 2026 11:02 PM
474Insider Transaction0001781549-26-000013Feb 6, 2026 11:02 PM
484Insider Transaction0001781549-26-000013Feb 6, 2026 11:02 PM
494Insider Transaction0001957554-26-000009Feb 6, 2026 11:00 PM
504Insider Transaction0001781549-26-000011Feb 5, 2026 9:48 PM
...

Aclaris Therapeutics, Inc. SEC Filings API

Pull Aclaris Therapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=ACRS&formtype=10-K,10-Q&api_key=YOUR_API_KEY